当前位置： SCI文献检索 > Therapeutic Advances in Gastroenterology期刊下所有文献 > Decision model analyses of upper endoscopy for gastric cancer screening and preneoplasia surveillance: a systematic review.

Decision model analyses of upper endoscopy for gastric cancer screening and preneoplasia surveillance: a systematic review.

Abstract：

Aims:Gastric cancer (GC) is the third leading cause of cancer death worldwide, but the burden of disease is not distributed evenly. GC screening routinely occurs in some high-incidence regions/countries and is generally cost-effective, which is attributed largely to the associated GC mortality reduction. In regions of low-intermediate incidence, less is known about the outcomes of GC screening and gastric precancer surveillance, including cost-effectiveness, since there are no comparative clinical studies. Decision analytic studies are informative in such instances where logistical limitations preclude "gold standard" study designs. We therefore aimed to conduct a systematic review of decision model analyses focused on endoscopic GC screening or precancer surveillance. Methods:We identified decision model analyses, including cost effectiveness and cost utility studies, of GC screening or preneoplasia surveillance. At minimum, articles were evaluated for: study country; analytic design; population and health states; time horizon; model assumptions; outcomes; threshold value(s) for "cost-effective" determination; and sensitivity analyses. Quality appraisal was performed using a modified Drummond's analytic scoring system. Data sources were PubMed, Web of Science, Embase, and the Cochrane Library. Results:We identified 17 studies (8 screening, 4 surveillance, and 5 screening and surveillance) that met full inclusion criteria. Endoscopic screening in countries of high GC incidence was cost-effective across all studies; targeted screening of high-risk populations within otherwise low-intermediate incidence countries was also generally cost-effective. Surveillance of gastric precancer, including atrophic gastritis or gastric intestinal metaplasia, was generally cost-effective. Most studies had high appraisal scores, with 4 (24%) studies achieving perfect scores on the Drummond scale. Conclusion:Decision model analyses offer a unique mechanism with which to efficiently explore the cost benefit of various prevention and early detection strategies. Based on this comprehensive systematic review, upper endoscopy for GC screening and gastric precancer surveillance might be cost-effective depending on the population and protocol. Focused efforts are especially needed not only to define the optimal approach, but also to define the populations within otherwise low-intermediate regions/countries who might benefit most.

journal_name

Therap Adv Gastroenterol

journal_title

Therapeutic advances in gastroenterology

authors

Canakis A,Pani E,Saumoy M,Shah SC

doi

10.1177/1756284820941662

subject

Has Abstract

pub_date

2020-07-16 00:00:00

pages

1756284820941662

eissn

1756-283X

issn

1756-2848

pii

10.1177_1756284820941662

journal_volume

pub_type

杂志文章,评审

在线工具

Decision model analyses of upper endoscopy for gastric cancer screening and preneoplasia surveillance: a systematic review.